Viking Therapeutics Could Be Pharma’s Next Big Buyout Target
Quick Read GLP-1 market growth is fueling Viking Therapeutics‘ (VKTX) momentum with VK2735 in Phase 3 and VK2809’s NASH success. Viking is advancing dual therapies amid a $150 billion obesity opportunity. With a recent big buyout offer for a rival not as far along as Viking, the biotech could draw a big pharma bid next. […]
AI’s Power Problem
In this podcast, Motley Fool analysts Nick Sciple, Seth Jayson, and Tim Beyers: Discuss the vast sums being invested in power infrastructure, and whether current plans will be enough to meet demand. Cover the opportunities and complications from filling the void with existing and emerging nuclear technology. Play a nuclear-themed game of Faker or Breaker. […]
GLP-1 RA May Cut Surgery Risk in Patients With IBD
Use of GLP-1 RA in patients with IBD and obesity and/or T2D is significantly associated with weight loss and a reduced risk for surgery. Medscape Medical News
With 800 million people living with obesity worldwide, Warsaw’s Holi secures €3 million to expand its digital treatment platform
Holi, a Polish HealthTech startup building a digital obesity clinic, has raised €3 million in Seed funding to enter new European markets and further develop its data-driven care platform. The round led by 4growth VC (Poland) with participation from YZR Capital (Germany), Heartfelt Capital (Germany) and a group of business angels. “Obesity treatment requires continuity […]
Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum
My guest is Dr. David Fajgenbaum, MD, professor of translational medicine and human genetics at the University of Pennsylvania. He explains how, unbeknownst to most doctors, many approved medications can successfully treat or even cure diseases other than the ones they are typically used to treat. He shares his story of escaping death from Castleman’s […]
Fall back: What’s changing this week in health
It’s November! Time for us Scorpios to shine. This week, we’re talking about falling back (literally and figuratively). From SNAP beneficiaries missing payments on November 1, to falling back on our broken health care system as open enrollment begins, to the time change messing with our health, a lot is shifting. We’re also flying a […]
STAT+: Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup
Pfizer on Monday said it filed a second lawsuit against Novo Nordisk and obesity startup Metsera, alleging that Novo’s attempt to outbid Pfizer to acquire the biotech is anticompetitive. The pharma giant alleges that Novo is trying to maintain its dominant position in the obesity market by eliminating Metsera, a potential competitor. It also alleges […]
Healthy lifestyle habits plus GLP-1 RA drugs can improve heart health of people with Type 2 diabetes
People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including heart attack, stroke or cardiovascular disease death, compared to people only taking the medication, according to a preliminary study to be presented at the American Heart […]
US Obesity Rates Have Dropped, And GLP-1 Drugs May Explain Why
Could this be a turning point?
Healthy lifestyle combined with newer diabetes medications lowers cardiovascular risk, preliminary study suggests
People with type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including heart attack, stroke or cardiovascular disease death, compared to people only taking the medication, according to a preliminary study presented at the American Heart Association’s Scientific […]